APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticles (LNP)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lipid Nanoparticles (LNP) Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchLipid Nanoparticles (LNP) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticles (LNP) Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticles (LNP) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticles (LNP) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticles (LNP) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Lipid Nanoparticles (LNP) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Lipid Nanoparticles (LNP) include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical and Lipoid, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Lipid Nanoparticles (LNP), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lipid Nanoparticles (LNP), also provides the revenue of main regions and countries. Of the upcoming market potential for Lipid Nanoparticles (LNP), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lipid Nanoparticles (LNP) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lipid Nanoparticles (LNP) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Lipid Nanoparticles (LNP) revenue, projected growth trends, production technology, application and end-user industry.

Lipid Nanoparticles (LNP) Segment by Company

Precision NanoSystems

Evonik

Merck KGaA

Genevant Sciences

Exelead

Avanti Polar Lipids

Nippon Fine Chemical

Lipoid

Lipid Nanoparticles (LNP) Segment by Type

mRNA-lipid Nanoparticle

siRNA-lipid Nanoparticle

Others

Lipid Nanoparticles (LNP) Segment by Application

Vaccines and Drugs

Scientific Research

Lipid Nanoparticles (LNP) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticles (LNP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticles (LNP) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticles (LNP).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Lipid Nanoparticles (LNP) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Lipid Nanoparticles (LNP) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Nanoparticles (LNP) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. mRNA-lipid Nanoparticle Major Player Table 3. siRNA-lipid Nanoparticle Major Player Table 4. Others Major Player Table 5. Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Vaccines and Drugs Major Player Table 7. Scientific Research Major Player Table 8. Lipid Nanoparticles (LNP) Industry Trends Table 9. Lipid Nanoparticles (LNP) Industry Drivers Table 10. Lipid Nanoparticles (LNP) Industry Opportunities and Challenges Table 11. Lipid Nanoparticles (LNP) Industry Restraints Table 12. Global Lipid Nanoparticles (LNP) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Lipid Nanoparticles (LNP) Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Lipid Nanoparticles (LNP) Market Share by Region (2021-2026) Table 15. Global Lipid Nanoparticles (LNP) Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Lipid Nanoparticles (LNP) Market Share by Region (2027-2032) Table 17. Global Lipid Nanoparticles (LNP) Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Lipid Nanoparticles (LNP) Revenue Market Share by Players (2021-2026) Table 19. Global Lipid Nanoparticles (LNP) Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Lipid Nanoparticles (LNP) Key Players Headquarters & Area Served Table 21. Global Lipid Nanoparticles (LNP) Players, Product Type & Application Table 22. Global Lipid Nanoparticles (LNP) Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Lipid Nanoparticles (LNP) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Lipid Nanoparticles (LNP) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Lipid Nanoparticles (LNP) Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Lipid Nanoparticles (LNP) Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2021-2026) Table 29. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2027-2032) Table 30. Global Lipid Nanoparticles (LNP) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Lipid Nanoparticles (LNP) Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Lipid Nanoparticles (LNP) Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2021-2026) Table 34. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2027-2032) Table 35. Precision NanoSystems Company Information Table 36. Precision NanoSystems Business Overview Table 37. Precision NanoSystems Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Precision NanoSystems Lipid Nanoparticles (LNP) Product Portfolio Table 39. Precision NanoSystems Recent Development Table 40. Evonik Company Information Table 41. Evonik Business Overview Table 42. Evonik Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Evonik Lipid Nanoparticles (LNP) Product Portfolio Table 44. Evonik Recent Development Table 45. Merck KGaA Company Information Table 46. Merck KGaA Business Overview Table 47. Merck KGaA Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Merck KGaA Lipid Nanoparticles (LNP) Product Portfolio Table 49. Merck KGaA Recent Development Table 50. Genevant Sciences Company Information Table 51. Genevant Sciences Business Overview Table 52. Genevant Sciences Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Genevant Sciences Lipid Nanoparticles (LNP) Product Portfolio Table 54. Genevant Sciences Recent Development Table 55. Exelead Company Information Table 56. Exelead Business Overview Table 57. Exelead Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Exelead Lipid Nanoparticles (LNP) Product Portfolio Table 59. Exelead Recent Development Table 60. Avanti Polar Lipids Company Information Table 61. Avanti Polar Lipids Business Overview Table 62. Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Avanti Polar Lipids Lipid Nanoparticles (LNP) Product Portfolio Table 64. Avanti Polar Lipids Recent Development Table 65. Nippon Fine Chemical Company Information Table 66. Nippon Fine Chemical Business Overview Table 67. Nippon Fine Chemical Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Nippon Fine Chemical Lipid Nanoparticles (LNP) Product Portfolio Table 69. Nippon Fine Chemical Recent Development Table 70. Lipoid Company Information Table 71. Lipoid Business Overview Table 72. Lipoid Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Lipoid Lipid Nanoparticles (LNP) Product Portfolio Table 74. Lipoid Recent Development Table 75. North America Lipid Nanoparticles (LNP) Revenue by Type (2021-2026) & (US$ Million) Table 76. North America Lipid Nanoparticles (LNP) Revenue by Type (2027-2032) & (US$ Million) Table 77. North America Lipid Nanoparticles (LNP) Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Lipid Nanoparticles (LNP) Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Lipid Nanoparticles (LNP) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Lipid Nanoparticles (LNP) Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Lipid Nanoparticles (LNP) Revenue by Country (US$ Million) & (2027-2032) Table 82. Europe Lipid Nanoparticles (LNP) Revenue by Type (2021-2026) & (US$ Million) Table 83. Europe Lipid Nanoparticles (LNP) Revenue by Type (2027-2032) & (US$ Million) Table 84. Europe Lipid Nanoparticles (LNP) Revenue by Application (2021-2026) & (US$ Million) Table 85. Europe Lipid Nanoparticles (LNP) Revenue by Application (2027-2032) & (US$ Million) Table 86. Europe Lipid Nanoparticles (LNP) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Lipid Nanoparticles (LNP) Revenue by Country (2021-2026) & (US$ Million) Table 88. Europe Lipid Nanoparticles (LNP) Revenue by Country (US$ Million) & (2027-2032) Table 89. China Lipid Nanoparticles (LNP) Revenue by Type (2021-2026) & (US$ Million) Table 90. China Lipid Nanoparticles (LNP) Revenue by Type (2027-2032) & (US$ Million) Table 91. China Lipid Nanoparticles (LNP) Revenue by Application (2021-2026) & (US$ Million) Table 92. China Lipid Nanoparticles (LNP) Revenue by Application (2027-2032) & (US$ Million) Table 93. Asia Lipid Nanoparticles (LNP) Revenue by Type (2021-2026) & (US$ Million) Table 94. Asia Lipid Nanoparticles (LNP) Revenue by Type (2027-2032) & (US$ Million) Table 95. Asia Lipid Nanoparticles (LNP) Revenue by Application (2021-2026) & (US$ Million) Table 96. Asia Lipid Nanoparticles (LNP) Revenue by Application (2027-2032) & (US$ Million) Table 97. Asia Lipid Nanoparticles (LNP) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Lipid Nanoparticles (LNP) Revenue by Region (US$ Million) & (2021-2026) Table 99. Asia Lipid Nanoparticles (LNP) Revenue by Region (US$ Million) & (2027-2032) Table 100. SAMEA Lipid Nanoparticles (LNP) Revenue by Type (2021-2026) & (US$ Million) Table 101. SAMEA Lipid Nanoparticles (LNP) Revenue by Type (2027-2032) & (US$ Million) Table 102. SAMEA Lipid Nanoparticles (LNP) Revenue by Application (2021-2026) & (US$ Million) Table 103. SAMEA Lipid Nanoparticles (LNP) Revenue by Application (2027-2032) & (US$ Million) Table 104. SAMEA Lipid Nanoparticles (LNP) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. SAMEA Lipid Nanoparticles (LNP) Revenue by Country (2021-2026) & (US$ Million) Table 106. SAMEA Lipid Nanoparticles (LNP) Revenue by Country (US$ Million) & (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Lipid Nanoparticles (LNP) Image Figure 2. Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lipid Nanoparticles (LNP) Market Size Share 2021 VS 2025 VS 2032 Figure 4. mRNA-lipid Nanoparticle Image Figure 5. siRNA-lipid Nanoparticle Image Figure 6. Others Image Figure 7. Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Lipid Nanoparticles (LNP) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Vaccines and Drugs Image Figure 10. Scientific Research Image Figure 11. Global Lipid Nanoparticles (LNP) Market Size (US$ Million) & (2021-2032) Figure 12. Global Lipid Nanoparticles (LNP) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Lipid Nanoparticles (LNP) Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Lipid Nanoparticles (LNP) Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Lipid Nanoparticles (LNP) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Lipid Nanoparticles (LNP) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2021-2032) Figure 19. Global Lipid Nanoparticles (LNP) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2021-2032) Figure 22. North America Lipid Nanoparticles (LNP) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032) Figure 24. North America Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032) Figure 25. North America Lipid Nanoparticles (LNP) Revenue Share by Country (2021-2032) Figure 26. United States Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Lipid Nanoparticles (LNP) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032) Figure 31. Europe Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032) Figure 32. Europe Lipid Nanoparticles (LNP) Revenue Share by Country (2021-2032) Figure 33. Germany Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Lipid Nanoparticles (LNP) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032) Figure 43. China Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032) Figure 44. Asia Lipid Nanoparticles (LNP) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032) Figure 46. Asia Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032) Figure 47. Asia Lipid Nanoparticles (LNP) Revenue Share by Region (2021-2032) Figure 48. Japan Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Lipid Nanoparticles (LNP) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032) Figure 56. SAMEA Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032) Figure 57. SAMEA Lipid Nanoparticles (LNP) Revenue Share by Country (2021-2032) Figure 58. Brazil Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • mRNA-lipid Nanoparticle
  • siRNA-lipid Nanoparticle
  • Others
Applications
  • Vaccines and Drugs
  • Scientific Research
Companies covered
  • Precision NanoSystems
  • Evonik
  • Merck KGaA
  • Genevant Sciences
  • Exelead
  • Avanti Polar Lipids
  • Nippon Fine Chemical
  • Lipoid

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lipid Nanoparticles (LNP) Market by Type
  3. 1.2.1 Global Lipid Nanoparticles (LNP) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 mRNA-lipid Nanoparticle
  5. 1.2.3 siRNA-lipid Nanoparticle
  6. 1.2.4 Others
  7. 1.3 Lipid Nanoparticles (LNP) Market by Application
  8. 1.3.1 Global Lipid Nanoparticles (LNP) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Vaccines and Drugs
  10. 1.3.3 Scientific Research
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Lipid Nanoparticles (LNP) Market Dynamics
  1. 2.1 Lipid Nanoparticles (LNP) Industry Trends
  2. 2.2 Lipid Nanoparticles (LNP) Industry Drivers
  3. 2.3 Lipid Nanoparticles (LNP) Industry Opportunities and Challenges
  4. 2.4 Lipid Nanoparticles (LNP) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Lipid Nanoparticles (LNP) Market Perspective (2021-2032)
  2. 3.2 Global Lipid Nanoparticles (LNP) Growth Trends by Region
  3. 3.2.1 Global Lipid Nanoparticles (LNP) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lipid Nanoparticles (LNP) Market Size by Region (2021-2026)
  5. 3.2.3 Global Lipid Nanoparticles (LNP) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Lipid Nanoparticles (LNP) Revenue by Players
  2. 4.1.1 Global Lipid Nanoparticles (LNP) Revenue by Players (2021-2026)
  3. 4.1.2 Global Lipid Nanoparticles (LNP) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Lipid Nanoparticles (LNP) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lipid Nanoparticles (LNP) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Lipid Nanoparticles (LNP) Key Players Headquarters & Area Served
  7. 4.4 Global Lipid Nanoparticles (LNP) Players, Product Type & Application
  8. 4.5 Global Lipid Nanoparticles (LNP) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Lipid Nanoparticles (LNP) Market CR5 and HHI
  11. 4.6.3 2025 Lipid Nanoparticles (LNP) Tier 1, Tier 2, and Tier 3
5 Lipid Nanoparticles (LNP) Market Size by Type
  1. 5.1 Global Lipid Nanoparticles (LNP) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Lipid Nanoparticles (LNP) Revenue by Type (2021-2032)
  3. 5.3 Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2021-2032)
6 Lipid Nanoparticles (LNP) Market Size by Application
  1. 6.1 Global Lipid Nanoparticles (LNP) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Lipid Nanoparticles (LNP) Revenue by Application (2021-2032)
  3. 6.3 Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Precision NanoSystems
  2. 7.1.1 Precision NanoSystems Company Information
  3. 7.1.2 Precision NanoSystems Business Overview
  4. 7.1.3 Precision NanoSystems Lipid Nanoparticles (LNP) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Precision NanoSystems Lipid Nanoparticles (LNP) Product Portfolio
  6. 7.1.5 Precision NanoSystems Recent Developments
  7. 7.2 Evonik
  8. 7.2.1 Evonik Company Information
  9. 7.2.2 Evonik Business Overview
  10. 7.2.3 Evonik Lipid Nanoparticles (LNP) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Evonik Lipid Nanoparticles (LNP) Product Portfolio
  12. 7.2.5 Evonik Recent Developments
  13. 7.3 Merck KGaA
  14. 7.3.1 Merck KGaA Company Information
  15. 7.3.2 Merck KGaA Business Overview
  16. 7.3.3 Merck KGaA Lipid Nanoparticles (LNP) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Merck KGaA Lipid Nanoparticles (LNP) Product Portfolio
  18. 7.3.5 Merck KGaA Recent Developments
  19. 7.4 Genevant Sciences
  20. 7.4.1 Genevant Sciences Company Information
  21. 7.4.2 Genevant Sciences Business Overview
  22. 7.4.3 Genevant Sciences Lipid Nanoparticles (LNP) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Genevant Sciences Lipid Nanoparticles (LNP) Product Portfolio
  24. 7.4.5 Genevant Sciences Recent Developments
  25. 7.5 Exelead
  26. 7.5.1 Exelead Company Information
  27. 7.5.2 Exelead Business Overview
  28. 7.5.3 Exelead Lipid Nanoparticles (LNP) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Exelead Lipid Nanoparticles (LNP) Product Portfolio
  30. 7.5.5 Exelead Recent Developments
  31. 7.6 Avanti Polar Lipids
  32. 7.6.1 Avanti Polar Lipids Company Information
  33. 7.6.2 Avanti Polar Lipids Business Overview
  34. 7.6.3 Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Avanti Polar Lipids Lipid Nanoparticles (LNP) Product Portfolio
  36. 7.6.5 Avanti Polar Lipids Recent Developments
  37. 7.7 Nippon Fine Chemical
  38. 7.7.1 Nippon Fine Chemical Company Information
  39. 7.7.2 Nippon Fine Chemical Business Overview
  40. 7.7.3 Nippon Fine Chemical Lipid Nanoparticles (LNP) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Nippon Fine Chemical Lipid Nanoparticles (LNP) Product Portfolio
  42. 7.7.5 Nippon Fine Chemical Recent Developments
  43. 7.8 Lipoid
  44. 7.8.1 Lipoid Company Information
  45. 7.8.2 Lipoid Business Overview
  46. 7.8.3 Lipoid Lipid Nanoparticles (LNP) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Lipoid Lipid Nanoparticles (LNP) Product Portfolio
  48. 7.8.5 Lipoid Recent Developments
8 North America
  1. 8.1 North America Lipid Nanoparticles (LNP) Revenue (2021-2032)
  2. 8.2 North America Lipid Nanoparticles (LNP) Revenue by Type (2021-2032)
  3. 8.2.1 North America Lipid Nanoparticles (LNP) Revenue by Type (2021-2026)
  4. 8.2.2 North America Lipid Nanoparticles (LNP) Revenue by Type (2027-2032)
  5. 8.3 North America Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032)
  6. 8.4 North America Lipid Nanoparticles (LNP) Revenue by Application (2021-2032)
  7. 8.4.1 North America Lipid Nanoparticles (LNP) Revenue by Application (2021-2026)
  8. 8.4.2 North America Lipid Nanoparticles (LNP) Revenue by Application (2027-2032)
  9. 8.5 North America Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032)
  10. 8.6 North America Lipid Nanoparticles (LNP) Revenue by Country
  11. 8.6.1 North America Lipid Nanoparticles (LNP) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Lipid Nanoparticles (LNP) Revenue by Country (2021-2026)
  13. 8.6.3 North America Lipid Nanoparticles (LNP) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Lipid Nanoparticles (LNP) Revenue (2021-2032)
  2. 9.2 Europe Lipid Nanoparticles (LNP) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Lipid Nanoparticles (LNP) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Lipid Nanoparticles (LNP) Revenue by Type (2027-2032)
  5. 9.3 Europe Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Lipid Nanoparticles (LNP) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Lipid Nanoparticles (LNP) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Lipid Nanoparticles (LNP) Revenue by Application (2027-2032)
  9. 9.5 Europe Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Lipid Nanoparticles (LNP) Revenue by Country
  11. 9.6.1 Europe Lipid Nanoparticles (LNP) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Lipid Nanoparticles (LNP) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Lipid Nanoparticles (LNP) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Lipid Nanoparticles (LNP) Revenue (2021-2032)
  2. 10.2 China Lipid Nanoparticles (LNP) Revenue by Type (2021-2032)
  3. 10.2.1 China Lipid Nanoparticles (LNP) Revenue by Type (2021-2026)
  4. 10.2.2 China Lipid Nanoparticles (LNP) Revenue by Type (2027-2032)
  5. 10.3 China Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032)
  6. 10.4 China Lipid Nanoparticles (LNP) Revenue by Application (2021-2032)
  7. 10.4.1 China Lipid Nanoparticles (LNP) Revenue by Application (2021-2026)
  8. 10.4.2 China Lipid Nanoparticles (LNP) Revenue by Application (2027-2032)
  9. 10.5 China Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lipid Nanoparticles (LNP) Revenue (2021-2032)
  2. 11.2 Asia Lipid Nanoparticles (LNP) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Lipid Nanoparticles (LNP) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Lipid Nanoparticles (LNP) Revenue by Type (2027-2032)
  5. 11.3 Asia Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Lipid Nanoparticles (LNP) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Lipid Nanoparticles (LNP) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Lipid Nanoparticles (LNP) Revenue by Application (2027-2032)
  9. 11.5 Asia Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Lipid Nanoparticles (LNP) Revenue by Country
  11. 11.6.1 Asia Lipid Nanoparticles (LNP) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Lipid Nanoparticles (LNP) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Lipid Nanoparticles (LNP) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lipid Nanoparticles (LNP) Revenue (2021-2032)
  2. 12.2 SAMEA Lipid Nanoparticles (LNP) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Lipid Nanoparticles (LNP) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Lipid Nanoparticles (LNP) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Lipid Nanoparticles (LNP) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Lipid Nanoparticles (LNP) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Lipid Nanoparticles (LNP) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Lipid Nanoparticles (LNP) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Lipid Nanoparticles (LNP) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Lipid Nanoparticles (LNP) Revenue by Country
  11. 12.6.1 SAMEA Lipid Nanoparticles (LNP) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Lipid Nanoparticles (LNP) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Lipid Nanoparticles (LNP) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst